Slovakia

 

Interview: Arjan Toor, CEO, Cigna Europe

Cigna now describes itself as “a global health service company” rather than an insurer and has reorganised its European operations. Toor has recently been promoted to CEO Europe. He says that the insurer, which has 15% (US$840m) of its revenue in Europe, doesn't want to verticalise through owning primary care providers but wants instead to provide an end-to-end user experience.

Ribera Salud CEE head talks to HBI about acquisition and strategy

Spanish hospital PPP operator Ribera Salud acquired its first hospital in CEE late last year, buying the bariatric-focused OB Klinika in Prague through its Slovakian subsidiary Pro Diagnostic Group (PDG). We asked its head of CEE if the acquisition could help it bid for potential privatisations in Czechia. 

Penta hospital sale looks less likely

The failure of Slovakian opposition parties to build a coalition or push through a bill banning verticalisation in healthcare could make a minority sale of Penta Investments's CEE hospital business PHI less likely.

€10bn battle of the labs as Unilabs and Synlab mull 2020 sales

Europe's largest lab groups could both sell in 2020, with Apax appointing Rothschild to explore a sale of Unilabs while Synlab's majority owner Cinven is also weighing up an exit. The sale values including debt could potentially reach €10bn combined.

Exclusive: Change at the top at Unilabs

Jos Lamers, 55, the man widely seen as the architect of modern-day Unilabs is moving away from a full-time role at the Pan-European lab and imaging platform, HBI can exclusively reveal. So what lies behind the move and who succeeds him as CEO?

Penta courts investors

HBI can exclusively reveal that multi-national CEE hospital chain Penta has started meeting with investors with a view to selling at least a minority stake, months after it denied the company was for sale. It tells HBI that it wants a partner who can support international expansion plans.

Find Us